Patient-Reported OUTcomes of Benralizumab in Real-World Use in Severe EosiNophilic Asthma Patients

CompletedOBSERVATIONAL
Enrollment

291

Participants

Timeline

Start Date

February 20, 2023

Primary Completion Date

April 10, 2025

Study Completion Date

April 10, 2025

Conditions
Severe Asthma
Trial Locations (24)

Unknown

Research Site, Bogotá

Research Site, Bucaramanga

Research Site, Ibagué

Research Site, Pereira

Research Site, Santiago de los Caballeros

Research Site, Santo Domingo

Research Site, Ahmedabad

Research Site, Ajmer

Research Site, Chennai

Research Site, Delhi

Research Site, Hyderabad

Research Site, Jaipur

Research Site, Kolkata

Research Site, Pune

Research Site, Secundrabad

Research Site, Vadodara

Research Site, Sabah Al Salem

Research Site, Muscat

Research Site, Doha

Research Site, Jeddah

Research Site, Riyadh

Research Site, Abu Dhabi

Research Site, Al Ain City

Research Site, Dubai

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AstraZeneca

INDUSTRY